312 related articles for article (PubMed ID: 22252140)
1. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity.
Astashkina A; Mann B; Grainger DW
Pharmacol Ther; 2012 Apr; 134(1):82-106. PubMed ID: 22252140
[TBL] [Abstract][Full Text] [Related]
2. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
3. Understanding mechanisms of toxicity: insights from drug discovery research.
Houck KA; Kavlock RJ
Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
[TBL] [Abstract][Full Text] [Related]
4. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
5. High-throughput human metabolism and toxicity analysis.
Lee MY; Dordick JS
Curr Opin Biotechnol; 2006 Dec; 17(6):619-27. PubMed ID: 17046235
[TBL] [Abstract][Full Text] [Related]
6. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart LA; Freyer JP; Hofstaedter F; Ebner R
J Biomol Screen; 2004 Jun; 9(4):273-85. PubMed ID: 15191644
[TBL] [Abstract][Full Text] [Related]
7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
8. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment.
Trosko JE; Chang CC
Toxicology; 2010 Mar; 270(1):18-34. PubMed ID: 19948204
[TBL] [Abstract][Full Text] [Related]
9. A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays.
Astashkina AI; Mann BK; Prestwich GD; Grainger DW
Biomaterials; 2012 Jun; 33(18):4700-11. PubMed ID: 22444643
[TBL] [Abstract][Full Text] [Related]
10. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
11. Organotypic systems in drug metabolism and toxicity: challenges and opportunities.
Dash A; Blackman BR; Wamhoff BR
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):999-1014. PubMed ID: 22632603
[TBL] [Abstract][Full Text] [Related]
12. In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates.
Olaharski AJ; Uppal H; Cooper M; Platz S; Zabka TS; Kolaja KL
Toxicol Lett; 2009 Jul; 188(2):98-103. PubMed ID: 19446241
[TBL] [Abstract][Full Text] [Related]
13. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities.
Lan SF; Starly B
Toxicol Appl Pharmacol; 2011 Oct; 256(1):62-72. PubMed ID: 21839104
[TBL] [Abstract][Full Text] [Related]
14. Defining the role of pharmacology in the emerging world of translational research.
Enna SJ; Williams M
Adv Pharmacol; 2009; 57():1-30. PubMed ID: 20230758
[TBL] [Abstract][Full Text] [Related]
15. Current and future needs for developmental toxicity testing.
Makris SL; Kim JH; Ellis A; Faber W; Harrouk W; Lewis JM; Paule MG; Seed J; Tassinari M; Tyl R
Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):384-94. PubMed ID: 21922641
[TBL] [Abstract][Full Text] [Related]
16. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
17. The role of body-on-a-chip devices in drug and toxicity studies.
Esch MB; King TL; Shuler ML
Annu Rev Biomed Eng; 2011 Aug; 13():55-72. PubMed ID: 21513459
[TBL] [Abstract][Full Text] [Related]
18. Microfluidic cell culture systems for drug research.
Wu MH; Huang SB; Lee GB
Lab Chip; 2010 Apr; 10(8):939-56. PubMed ID: 20358102
[TBL] [Abstract][Full Text] [Related]
19. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell technologies and drug discovery.
Jensen J; Hyllner J; Björquist P
J Cell Physiol; 2009 Jun; 219(3):513-9. PubMed ID: 19277978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
